Katelyn R. Ludwig
Kate completed her PhD in Biochemistry from the University of Notre Dame in 2019, where she used mass spectrometry-based proteomics to study colorectal cancer. In 2019, Kate joined the Genetics Branch in the Center for Cancer Research at the National Cancer Institute for her postdoctoral training, where she studied the oncogenic transcription factor EWS-FLI1 in Ewing sarcoma. Kate joined the Integrative Physiology of Aging lab in 2021 as the Biochemistry Core Director. Outside of the laboratory, Kate enjoys photography, hiking, and spending time with her cats.